Loading...
Indian Pharmaceutical Exporter · #4 for Vati · $1.9M export value · DGFT Verified
Laborate Pharmaceuticals India Ltd is the #4 Indian exporter of Vati with $1.9M in export value and 215 verified shipments. Laborate Pharmaceuticals India Ltd holds a 7.1% market share in Vati exports across 18 countries.
| 15 |
| 2.1% |
| MAURITANIA | $31.9K | 9 | 1.5% |
| TAJIKISTAN | $30.9K | 10 | 1.4% |
| BURUNDI | $30.5K | 17 | 1.4% |
| THAILAND | $30.3K | 10 | 1.4% |
| ANGOLA | $19.7K | 2 | 0.9% |
Laborate Pharmaceuticals India Ltd exports Vati to 18 countries. The largest destination is NIGERIA accounting for 58.4% of Laborate Pharmaceuticals India Ltd's Vati shipments, followed by KENYA (22.4%) and TURKEY (3.9%). These destinations reflect Laborate Pharmaceuticals India Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EMBASSY PHARMACEUTICAL AND | NIGERIA | $981.3K | 84 |
| INVESTMENT & MORTGAGES BANK LTD. | KENYA | $178.6K | 34 |
| EMBASSY PHARMACEUTICAL & CHEMICALS | NIGERIA | $163.6K | 6 |
| BRITISH PHARMA LTD | UZBEKISTAN | $80.8K | 18 |
| TO THE ORDER OF EMBASSY PHARMACEUTI | NIGERIA | $79.9K | 3 |
| KAMCARE PHARMA LTD | KENYA | $50.0K | 1 |
| ROYAL PHARMA 2011 LTD. (UGANDA) | KENYA | $50.0K | 1 |
| TO THE ORDER OF ROYAL PHARMA 2011 L | KENYA | $50.0K | 1 |
| ROYAL PHARMA 2011 LTD. | KENYA | $48.4K | 1 |
| HEALTHCARE LTD | KENYA | $44.9K | 2 |
Laborate Pharmaceuticals India Ltd supplies Vati to 43 buyers globally. The largest buyer is EMBASSY PHARMACEUTICAL AND (NIGERIA), followed by INVESTMENT & MORTGAGES BANK LTD. (KENYA) and EMBASSY PHARMACEUTICAL & CHEMICALS (NIGERIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $16.4M worth of Vati through 5,725 shipments from 427 suppliers to 141 countries, serving 869 buyers globally. Laborate Pharmaceuticals India Ltd contributes $1.9M to this total, accounting for 7.1% of India's Vati exports. Laborate Pharmaceuticals India Ltd ships Vati to 18 countries through 43 buyers.
Laborate Pharmaceuticals India Ltd's average Vati shipment value is $8.7K per consignment, based on 215 shipments totaling $1.9M. The largest destination is NIGERIA (58.4% of Laborate Pharmaceuticals India Ltd's Vati exports).
Laborate Pharmaceuticals India Ltd ranks #4 among 427 Indian Vati exporters with a 7.1% market share. The top 3 exporters are MANKIND PHARMA LIMITED ($4.1M), MICRO LABS LIMITED ($2.5M), EUGIA PHARMA SPECIALITIES LIMITED ($2.0M). Laborate Pharmaceuticals India Ltd processed 215 shipments to 18 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| 1-841 EMBASSY VIT B12 INJ. 2ml(Cyanocobalamin USP 1000mcg/ml (as anhydrous), Phenol USP (as preservative) 0.5%w/v) (QTY: | $96.5K | 2 |
| 1-896 LABQUIN INJ. 30ML(CHLOROQUINE PHOSPHATE 40MG/ML, CHLOROBUTANOL 0.5%W/V (ASPRESERVATIVE), BENZYLALCOHOL 2%V/V (AS | $75.5K | 4 |
| 1-768 LABQUIN INJ. 30ML(CHLOROQUINE PHOSPHATE 40MG/ML, CHLOROBUTANOL 0.5%W/V (ASPRESERVATIVE), BENZYLALCOHOL 2%V/V (AS | $66.2K | 2 |
| 1-300 MALAREST INJECTION 2ML (Quinine Dihydrochloride 300mg/ml, Benzyl Alcohol (as preservative) 2%w/v) BatchNos:OQDIE-0 | $50.0K | 1 |
| 1-2113 DICLOFENAC SODIUM INJ 3ml (Diclofenac Sodium BP 25mg/ml, Benzyl Alcohol BP (as preservative) 4%v/v) (QTY: 42260 B | $50.0K | 1 |
| 1 740 DICLOFENAC SODIUM INJ 3ml Diclofenac Sodium BP 25mg ml Benzyl Alcohol BP as preservative 4 v v QTY 14800 BO | $50.0K | 1 |
| 1 673 HYOSCINE INJECTION 1ML Hyoscine Butylbromide BP 10mg ml Chlorobutanol BP as preservative BP 0 5 w v QTY 16152 | $50.0K | 1 |
| 1-576 LABQUIN INJ. 30ML(CHLOROQUINE PHOSPHATE 40MG/ML, CHLOROBUTANOL 0.5%W/V (ASPRESERVATIVE), BENZYLALCOHOL 2%V/V (AS | $49.6K | 2 |
| 1-1400 DICLOFENAC SODIUM INJ 3ml (Diclofenac Sodium BP 25mg/ml, Benzyl Alcohol BP (as preservative) 4%v/v) (QTY: 28000 B | $48.4K | 1 |
| 1-512 LABQUIN INJ. 30ML(CHLOROQUINE PHOSPHATE 40MG/ML, CHLOROBUTANOL 0.5%W/V (ASPRESERVATIVE), BENZYLALCOHOL 2%V/V (ASNOS | $44.0K | 6 |
Laborate Pharmaceuticals India Ltd exports 165 distinct Vati formulations including tablets, capsules, syrups, and combination drugs. The top formulation is 1-841 EMBASSY VIT B12 INJ. 2ml(Cyanocobalamin USP 1000mcg/ml with 2 shipments worth $96.5K.
What Laborate Pharmaceuticals India Ltd must comply with to export Vati to its top destination countries
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MICRO LABS LIMITED | $2.5M | 49 | 5 | $50.0K |
| 3 | EUGIA PHARMA SPECIALITIES LIMITED | $2.0M | 40 | 2 | $50.0K |
| 4 | LABORATE PHARMACEUTICALS INDIA LTD ★ | $1.9M | 215 | 18 | $8.7K |
| 5 | MSN LABORATORIES PRIVATE LIMITED | $1.3M | 45 | 3 | $28.2K |
| 6 | SENTISS PHARMA PRIVATE LIMITED | $854.2K | 36 | 3 | $23.7K |
Laborate Pharmaceuticals India Ltd ranks #4 among 427 Indian Vati exporters. Average shipment value of $8.7K compared to the market average of $38.3K. The closest competitors by value are MICRO LABS LIMITED and EUGIA PHARMA SPECIALITIES LIMITED.
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 1,284 | 22.4% |
| DELHI AIR | 1,026 | 17.9% |
| SAHAR AIR | 379 | 6.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 306 | 5.3% |
| NHAVA SHEVA SEA (INNSA1) | 179 | 3.1% |
| PATLI ICD | 171 | 3.0% |
| Delhi Air | 170 | 3.0% |
| Delhi Air Cargo | 141 | 2.5% |
Latest developments and market context
Detailed market intelligence for Vati — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 141+ countries, 869+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Laborate Pharmaceuticals India Ltd's Vati exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Laborate Pharmaceuticals India Ltd
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Laborate Pharmaceuticals India Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vati. For current shipment-level data, contact TransData Nexus.